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In the previous issue of Critical Care, Takala and 
colleagues [1] published a multicenter randomized con-
trolled trial (RCT) investigating the use of less invasive 
cardiac output monitoring in hemodynamically unstable 
patients admitted to the intensive care unit (ICU). In this 
study, patients were randomly assigned to be treated with 
(MICO group) or without (control group) a minimally 
invasive cardiac output monitor based on pulse pressure 
analysis (FloTrac Vigileo, version 1.07; Edwards Lifesciences, 
Irvine, CA, USA).
Th e hypothesis of the study was that if clinicians were 
given extra information on cardiac output they would be 
able to manage hemodynamic instability in a more 
eﬀ ective way. Th e primary outcome of the investigation 
was the achievement of hemodynamic stability within 6 
hours of entering the study. ICU mortality and hospital 
mortality were considered secondary outcomes. Th ere 
were no diﬀ erences in any of these outcomes between the 
control and protocol groups.
Th e conclusion from these results is that early monitor ing 
of cardiac output in patients admitted with hemo dynamic 
instability to the ICU is not associated with an improved 
outcome. Th ere may be several explanations for this. Th e 
literature on the use of hemodynamic monitoring in 
improving the outcome of either septic or surgical 
patients provides two constant features: the use of 
treatment protocols with speciﬁ c hemodynamic targets 
and very early application of these protocols. Th e use of 
such hemodynamic monitoring is often referred to as 
early goal-directed therapy (EGDT).
In this study, there was no protocolized treatment. 
Th ere were qualitative guidelines instead of speciﬁ c 
hemodynamic targets. Th e authors acknowledge that this 
is one of the limitations of the study and that it may 
explain the lack of a positive result. Interestingly, this lack 
of outcome beneﬁ t when hemodynamic monitoring is 
used without a protocol is consistent with data in the 
literature. RCTs in which pulmonary artery catheters 
(PACs) have been used without a protocol have not 
shown any outcome beneﬁ t [2,3]. In contrast, when the 
PAC has been coupled with an EGDT approach, there 
have been improved outcomes [4-8]. Importantly, the 
targets and the intervention in the protocol need to be 
very speciﬁ c while the use of guidelines is not associated 
with an improved outcome [9]. However, there are RCTs 
in which the use of PACs coupled with treatment 
protocols has not shown any outcome beneﬁ t [10,11]. In 
these studies, the protocols were not applied ‘early’ and 
patients were enrolled even if organ failure had developed 
[12]. It is clear, therefore, that timing of entry into a 
protocol is fundamental to its success or failure.
Th e present study was started promptly: in the MICO 
group, arterial pressure monitoring was achieved 
20 minutes after admission to the ICU and entry into the 
study occurred less than 1 hour later. It is highly unlikely 
that this period could be signiﬁ cantly shortened. It is 
probably signiﬁ cant that the median time from hospital 
to ICU admission is 13 hours and has a very substantial 
range. It may be, therefore, that the patients were already 
too sick to beneﬁ t from any hemodynamic intervention. 
In septic patients, goal-directed therapy started in the 
emergency department [13] has demonstrated great 
beneﬁ ts in survival whereas it makes no diﬀ erence in 
survival if applied late [10,11].
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Takala and colleagues [1] used a Vigileo (version 1.07). 
Th is monitor was used successfully in two recently 
published trials: one by Benes and colleagues [14] with 
Vigileo version 1.10 and one by Cecconi and colleagues 
[15] with version 1.07. It is important to note that, in 
these two studies, the monitor was used in a diﬀ erent 
population (elective surgical patients). It may be that the 
monitor provides more accurate information in relatively 
stable, elective surgery patients, in contrast to the 
heterogeneous hemodynamically unstable population of 
patients in the present study, in which the data provided 
by the monitor may be less accurate.
We concur with the authors that the main limitation of 
this study is the lack of a protocol in the MICO group. No 
study in the literature demonstrates a beneﬁ t from the 
use of hemodynamic monitoring in the absence of a 
protocol, a ﬁ nding that this study seems to conﬁ rm.
Th e authors must be congratulated for studying the use 
of less invasive hemodynamic monitoring in such a 
challenging population. Th e role of EGDT in 
hemodynamically unstable patients in the ICU is, 
therefore, still unproven. A study that proves this role 
would be a major contribution to the management of 
critically ill, unstable patients.
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